These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4692988)

  • 1. Comparison of activated partial thromboplastin reagents.
    Sibley C; Singer JW; Wood RJ
    Am J Clin Pathol; 1973 Apr; 59(4):581-6. PubMed ID: 4692988
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of composition of reagents for activated partial thromboplastin time on their sensitivity during analysis of blood coagulation factors].
    Berkovskiĭ AL; Vasil'ev SA; Sergeeva EV; Kozlov AA
    Klin Lab Diagn; 2000 Apr; (4):34-8. PubMed ID: 10878941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the effect of reagent modification on routine laboratory coagulation tests.
    Gentry PA; Feldman BF; O'Neill SL
    Equine Vet J; 1992 Jan; 24(1):30-2. PubMed ID: 1555536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII (antihemophilic factor) assay results in the 1976 College of American Pathologists Survey Program.
    Harms CS; Triplett DA; Koepke JA
    Am J Clin Pathol; 1978 Sep; 70(3 Suppl):560-2. PubMed ID: 707422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standardization of the thromboplastin generation test for the determination of antihemophilic globulin A (VIII) and B (IX)].
    Bergmann A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):376-80. PubMed ID: 4195285
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of partial thromboplastin time. 3].
    Yatani N; Shimoda T; Kanuma K; Genba A; Tzsukada H
    Rinsho Byori; 1971 Aug; 19():Suppl:247. PubMed ID: 5167945
    [No Abstract]   [Full Text] [Related]  

  • 8. The comparison of CS-2500 and BCS XP coagulation analyzers for Factor VIII and Factor IX one-stage clotting assays.
    Genc S; Aydin AF; Karaca E; Ömer B
    Int J Lab Hematol; 2019 Oct; 41(5):e124-e127. PubMed ID: 31034727
    [No Abstract]   [Full Text] [Related]  

  • 9. An Easy Method to Eliminate the Effect of Lupus Anticoagulants in the Coagulation Factor Assay.
    Tang N; Yin S
    Clin Lab; 2016 Jul; 62(7):1363-1365. PubMed ID: 28164630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin time standardization: Proposal of the standards committee, College of American Pathologists.
    Miale JB; LaFond DJ
    Thromb Diath Haemorrh Suppl; 1968; 35():107-1. PubMed ID: 5761058
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolongation of the activated partial thromboplastin time associated with poor venipuncture technic.
    McPhedran P; Clyne LP; Ortoli NA; Gagnon PG; Sanders FJ
    Am J Clin Pathol; 1974 Jul; 62(1):16-20. PubMed ID: 4833734
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutions.
    Barna L; Triplett DA
    Ric Clin Lab; 1989; 19(4):345-54. PubMed ID: 2517350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of the partial thromboplastin time for the clinical diagnosis].
    Norpoth L; Surmann T; Schulze M
    Dtsch Med Wochenschr; 1968 Jul; 93(30):1437-8 passim. PubMed ID: 5668255
    [No Abstract]   [Full Text] [Related]  

  • 14. A micromethod for clotting tests and coagulation factor assays.
    Exner T; Margolis J; Rickard KA
    Clin Lab Haematol; 1980; 2(3):227-30. PubMed ID: 6775862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A precision study of coagulation factor assay technics.
    Palkuti HA; Longberry JF
    Am J Clin Pathol; 1973 Feb; 59(2):231-5. PubMed ID: 4687625
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thromboplastin generation test and possible errors in its reproducibility].
    Tarasova LN
    Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence of discrepant commercial ISI assignment.
    Holland LJ; Lawrie AS; Hunt BJ
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):493-4; author reply 495. PubMed ID: 1420828
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of various activated partial thromboplastin reagents in the laboratory control of heparin therapy.
    Soloway HB; Cornett BM; Grayson JW
    Am J Clin Pathol; 1973 Apr; 59(4):587-90. PubMed ID: 4692989
    [No Abstract]   [Full Text] [Related]  

  • 19. Standardization of prothrombin and activated partial thromboplastin time reagents and controls.
    Patterson BB; Pulis JL
    Am J Clin Pathol; 1976 Feb; 65(2):213-9. PubMed ID: 1251814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The International Normalized Ratio in the control of anticoagulation therapy with dicoumarin].
    Sikorová J; Vorlová Z
    Cas Lek Cesk; 1987 Feb; 126(6):184-7. PubMed ID: 2434231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.